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S U M M A R Y
Background: Mucormycosis caused by Saksenaea erythrospora is rarely reported in humans. Three
previous cases have been reported in the literature, two associated with trauma (a sailing accident in
Argentina and a combat trauma in Iraq) and one as a cause of invasive rhinosinusitis (India), all in
immunocompetent patients . The ﬁrst case of mucormycosis following esthetic surgery, associated with
medical tourism, is reported herein.
Case report: A case study of an S. erythrospora infection in an immunocompetent woman after the
completion of esthetic surgery (dermolipectomy and breast augmentation) is reported. The infection
presented as a rapidly progressive necrotizing infection of the skin and soft tissue, which required a
bilateral mastectomy and extensive surgical debridement associated with prolonged antifungal therapy.
The organism was identiﬁed phenotypically and conﬁrmed biologically after rDNA ampliﬁcation and
sequencing. Two months later, the patient remains hospitalized awaiting the start of reconstructive
surgeries. The present case is, to the best of the authors’ knowledge, the ﬁrst report from Colombia.
Conclusions: Mucormycosis should be considered in the differential diagnosis of necrotizing infections of
the skin and soft tissue that evolve rapidly after cosmetic surgery performed in tropical or subtropical
countries.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Mucormycosis is a rare infection caused by fungi of the order
Mucorales.1,2 Mucormycosis typically occurs in patients with
comorbidities such as neutropenia, hematological malignancy,
diabetes, or steroid use. There are several different clinical
manifestations of the infection, including rhinocerebral, pulmo-
nary, gastrointestinal, cutaneous, or disseminated onset, which
typically correlate with the predisposing condition.3§ The sequence obtained in this study was submitted to GenBank under accession
number KU951560.
* Corresponding author. Tel.: +57 13143302367.
E-mail address: caalvarezmo@unal.edu.co (C.A. A´lvarez-Moreno).
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1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Rhizopus spp are the most common causes of invasive
mucormycosis (50%), followed by Mucor spp, Apophysomyces spp,
and Lichtheimia spp. Saksenaea vasiformis is responsible for less
than 2% of these infections, most of which occur in tropical or
subtropical climates.4
S. vasiformis was previously considered to be the only species of
the genus, until the discovery of Saksenaea oblongispora and
Saksenaea erythrospora in 2010.5 Although these fungi will grow
on routine mycological media, they do not sporulate easily, which
makes them difﬁcult to identify. Therefore, the use of molecular
methods based on PCR ampliﬁcation and internal transcribed spacer
(ITS) sequencing is necessary. Being a soil saprophyte, infections by
these microorganisms are typically associated with a history of
trauma, burns, bites, or animal bites. Additionally, these organisms
have been associated with nosocomial infections, such as intramus-
cular injections, catheter-related bloodstream infections, andciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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have been reported in previously healthy or nonimmunocompro-
mised patients; these infections are clinically characterized by
necrotizing fasciitis or cellulitis that rapidly spreads to the
surrounding tissues.
2. Case report
A previously healthy 29-year-old Colombian woman with a
history of dermolipectomy and breast augmentation performed in
the city of Maracaibo, Venezuela presented fever and chills
associated with pain and erythema in the surgical wound of the
right breast on the ﬁfth postoperative day. The patient underwent an
operation for the removal of the breast implants, and broad-
spectrum antibiotic therapy was initiated. The patient was admitted
to the local hospital in Valledupar, Colombia on the ninth
postoperative day due to the persistence of inﬂammatory signs in
the right breast, leukocytosis (19  109 cells/l ), and neutrophilia
(80%). Blood and surgical wound cultures were taken, and
antimicrobial therapy with meropenem and vancomycin was
initiated. On the 11th postoperative day, a clinical deterioration
was evident, and the patient reported increased pain at the surgical
site; the presence of skin necrosis, with the production of pus in the
right breast, was noted (Figure 1A). A radical right breast
mastectomy, surgical debridement of the necrotic tissue, and
drainage were performed. In addition, a sample was taken for
histopathology studies and microbiological cultures. Following the
surgical procedure, the patient was admitted to the intensive care
unit for invasive mechanical ventilation and was given antibiotic
management with tigecycline and cefepime.
Forty-eight hours later, the patient had an increased white
blood cell count (64  109 cells/l), and a persistent clinical
deterioration was evident. The left periareolar area was erythem-
atous and there was soft tissue necrosis extending from the rightFigure 1. (A) Image showing the mammoplasty and dermolipectomy on the 11th postsu
Postoperative image following mastectomy of the right breast. (C) Intraoperative image a
tissue. (D) Microscopic image of the fungal columella on PDA agar (40). (E) Classical str
(F) A section of the patient’s skin and soft tissue infected with mucormycosis stained wit
with branching at right angles (40).axillary line to the left breast and upper-third of the abdomen
(Figure 1B). A radical left mastectomy and debridement of the
necrotic tissue were then performed (Figure 1C).
Three sets of blood cultures were persistently negative for
bacteria, and direct microbiological examination of the samples did
not show the presence of fungi, bacteria, or mycobacteria (Gram and
Ziehl–Neelsen stains were negative). In addition, cultures of the
necrotic tissue for bacteria and mycobacteria did not show signs of
microbial growth. However, the primary fungal culture of this
clinical specimen showed the presence of mycelial fungi with no
septate hyphae, suggestive of mucormycosis. Amphotericin B and
caspofungin were thus added to the treatment regime. The patient
was then transferred to a hospital with greater capabilities 72 h later
for hyperbaric oxygen therapy. Two months later, the patient
remains hospitalized awaiting the start of reconstructive surgeries.
The fungal isolate was incubated at 37 8C for 10 days in potato
dextrose agar (PDA; Scharlab S.L, Barcelona, Spain), malt extract
agar (MEA; Scharlab S.L), and Sabouraud–glucose agar (SDA;
Scharlab S.L). Rapidly growing colonies with white aerial mycelia
were found in all of the samples. Microscopic examination showed
sterile broad non-septate hyphae with sporadic hemispherical
columella (Figure 1D). Despite multiple cultures in various
mycological media, it was not possible to obtain fungal sporula-
tion. The strains were then subcultured in Czapek Dox agar (CZA;
Oxoid, UK) and showed the presence of dichotomously branching
rhizoids at the base of the hyaline sporangiophores and the typical
ﬂask-shaped sporangia (Figure 1E).
Histopathological analyses showed abundant granulated tissue
with the foreign body reaction and multiple aseptate hyphae in the
intravascular space with branching at right angles, suggestive of
mucormycosis (Figure 1F). The fungal culture was sent to the
Laboratorio Corpogen Corporation for molecular identiﬁcation. This
was performed by ampliﬁcation and sequencing of the ITS and 5.8S
RNA of the nuclear rDNA by PCR using the primers ITS1 (50-TCC GTArgical day; skin necrosis with the production of pus in the right breast is shown. (B)
fter mastectomy of the left breast and debridement of the surrounding skin and soft
uctures (sporangium, sporangiophore, rhizoids) of Saksenaea spp on CZA agar (40).
h hematoxylin and eosin, showing broad aseptate hyphae in the intravascular space
Figure 2. Phylogenetic trees were constructed using the 19 closest sequences, based on the information in the NCBI (nr/nt) database. KU951560 corresponds to the nucleotide
sequence analyzed.
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and ITS 5 (50-GGAAGTAAAAGTCGTAACAAGG-30). The 768-bp
sequencing product was compared with the GenBank database
using BLASTN (National Center for Biotechnology Information
(NCBI)) and UNITE. It showed 98.2% homology of its full-length
sequence with the species S. erythrospora from the family
Saksenaeaceae (Figure 2 ). The sequence obtained in this study
was submitted to GenBank under accession number KU951560.
3. Discussion
This is the ﬁrst case of mucormycosis following a breast
augmentation procedure reported in the literature and the fourth
reported case of a human infection caused by S. erythrospora. Two
previous case were associated with trauma (a sailing accident in
Argentina and a combat trauma in Iraq) and one as a cause of invasive
rhinosinusitis (India), all in immunocompetent patients.8–10
The treatment of these infections should include aggressive
surgical debridement, antifungal therapy, and correction of the
predisposing condition when possible. It is incorrectly assumed
that the antifungal treatment of mucormycosis is the same
regardless of the species involved. However, for Saksenaea spp,
antifungal susceptibility testing has shown low minimum
inhibitory concentrations (MICs) for posaconazole, itraconazole,
and terbinaﬁne and high MICs for amphotericin B, echinocandins,
and voriconazole.5 These ﬁndings are important for selecting the
appropriate treatment for these infections, particularly with the
empirical use of amphotericin B. The utility of combining
antifungal therapy, the use of a hyperbaric oxygen chamber, and
interferon therapy is not entirely clear.6–9,11,12
Medical tourism is an increasingly common activity that has
many beneﬁts, including lower cost, avoidance of long waiting
times, and access to particular health services, technologies, or
procedures. Many procedures may be unavailable in certain areas,
too expensive, or not covered by local health systems, or may evenbe considered illegal in some countries.13,14 Elective cosmetic
procedures are the most common medical tourism surgeries, and
the most frequent complication is infection of the surgical site.11,12
In addition, there is a risk of acquiring microorganisms with
multidrug resistance proﬁles that may be unusual or not seen in
the home country, with catastrophic complications such as those
that occurred in the present case.13,14 It is noteworthy that the
microbes that are most often associated with this type of surgical
procedure are the non-tuberculous mycobacteria.13
Although many of the institutions involved in medical tourism
work very well and are organized with high quality standards, many
procedures may be performed in an unconventional way or in
institutions that either do not meet the appropriate infection control
standards or have minimal patient monitoring and post-surgical
recovery times. It is necessary to advise patients on the procedure-
related risks of medical tourism, including the risk of infection; in
turn, physicians must be vigilant and suspect organisms based on
the local epidemiological characteristics of the locations where the
medical tourism procedures were performed.
In conclusion, mucormycosis should be considered in the
differential diagnosis of necrotizing infections of the skin and soft
tissue that evolve rapidly after cosmetic surgeries performed in
tropical or subtropical countries. Physicians should advise patients
on the prevention of surgical site infections, because the risk of
such infections can be catastrophic and often fatal. Finally, this is
the ﬁrst report, to the authors’ knowledge, of an infection with S.
erythrospora in Colombia, conﬁrming the presence of this
Mucorales species in South America.
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